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Abstract
Aims/hypothesis To determine the extent to which gestational
fasting and postload levels of glucose explain differences in
infant fat mass between UK-born Pakistani and white British
infants.
Methods Analyses were undertaken in a prospective pregnan-
cy cohort study of 1,415 women and their singleton live-born
infants (629 white British and 786 Pakistani). Infant fat mass
was assessed by cord-blood leptin levels and fetal insulin
secretion by cord-blood insulin levels. Maternal OGTTs were
completed at 26–28 weeks of gestation.
Results Pakistani women had higher fasting and postload
glucose levels and greater incidence of gestational diabetes
than white British women. Higher fasting and postload glu-
cose levels were associated with higher cord-blood levels of
insulin and leptin in all participants, irrespective of ethnicity.
Cord-blood leptin levels were 16% (95% CI 6, 26) higher in
Pakistani than in white British infants. After adjustment for
fasting glucose levels, this difference attenuated to 7% (−3,
16), and with additional adjustment for cord-blood insulin
levels it attenuated further to 5% (−4, 14). Path analyses sup-
ported the hypothesis that fasting glucose levels mediate the
relationship of Pakistani ethnicity to greater fat mass at birth, as
measured by cord-blood leptin levels; on average, 19% of this
mediation involved fetal insulin secretion. Postload glucose
levels did not act as an important mediator of ethnic differences
in cord-blood leptin levels. Results were very similar when 130
women with gestational diabetes were removed.
Conclusions/interpretation These novel findings suggest a
role of maternal pregnancy glycaemia in mediating differ-
ences in fat mass between Pakistani and white British infants.
Keywords Birthweight . Cord-blood insulin . Cord-blood
leptin . Epidemiology . Ethnicity . Gestational diabetes .
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Introduction
For a given BMI, South Asian compared with white European
adults have greater fat mass, leading to the suggestion that
they have a ‘thin-fat’ insulin-resistant phenotype that under-
lies their increased type 2 diabetes risk [1–3]. Recent evidence
suggests that this phenotype is present in children [4–6], and
possibly at birth [7]. For a given birthweight, South Asian
babies born in India have been found to be fatter (as measured
by subscapular and triceps skinfolds or cord-blood leptin
levels) than white European babies born in Europe or the
USA [7–9]. These differences may reflect different socioeco-
nomic, lifestyle and healthcare characteristics between people
living in India compared with those in Western countries.
However, we have recently shown similar results when com-
paring babies of Pakistani origin conceived and born in the
UK with white British babies born in the same maternity unit
[10].
Greater gestational hyperglycaemia amongst South Asian
women [11–14] is a plausible exposure that could contribute
to greater fat mass at birth in South Asian infants because (1)
greater circulating pregnancy fasting and postload glucose
concentrations promote fetal insulin secretion and fat accre-
tion in a linear dose–response fashion [15–19]; and (2) an
increased risk of gestational diabetes mellitus (GDM),
hyperglycaemia and type 2 diabetes in people of South Asian
origin is well established [1, 11–14, 20–25].
The aim of this study was to determine the extent to which
differences between Pakistani and white British women in
gestational glucose levels mediate differences in cord-blood
leptin levels (a valid proxy for birth fat mass that has been
used in previous studies for this purpose [7, 10, 26, 27]). We
also investigated the role of cord-blood insulin levels in these
relationships. This work extends our earlier work [10], which
did not explore possible mediators of ethnic differences in
cord-blood leptin levels at birth. To the best of our knowledge,
the role of maternal gestational glycaemia in mediating differ-
ences in infant fatness between Pakistani (or any other South
Asian group) and white British infants has not been previously
explored.
Methods
This study was approved by the Bradford Research Ethics
Committee (ref 06/Q1202/48). All participants provided writ-
ten informed consent. The study was undertaken in a planned
pseudo-randomly selected subgroup of the Born in Bradford
(BiB) cohort in whom relevant cord-blood outcomes were
assayed. BiB is a prospective pregnancy cohort study that
collected detailed information from 12,453 women who ex-
perienced 13,776 pregnancies resulting in 13,818 births [28].
To be eligible for BiB, women had to be booked to give birth
between March 2007 and December 2010 in the maternity
department at Bradford Royal Infirmary, in the North of
England [28].
BiB women were recruited primarily at their OGTT ap-
pointment (26–28 weeks’ gestation). All women booked for
delivery in Bradford are offered a 75 g OGTT (comprising
fasting and 120min postload samples) at around 26–28weeks’
gestation. At recruitment, BiB participants completed an
interviewer-administered questionnaire. Interviews were con-
ducted in English or in a range of South Asian languages,
including Urdu, Mirpuri, Bengali and Punjabi [28].
To be eligible for the cord-blood substudy, BiB participants
had to have a live birth from a singleton pregnancy that
occurred between mid-October 2008 and mid-October 2009.
Electronic supplementary material (ESM) Table 1 shows that
the distributions of participant characteristics are similar in the
subgroup used for this study and those in the whole cohort of
singleton live births. Figure 1 shows further exclusions from
this study. Participants had to be of Pakistani or white British
origin. The BiB cohort includes all eligible women, irrespec-
tive of their ethnic origin, but for this study other ethnic groups
were either too small to be examined separately or were not
relevant to the comparison of South Asian and white Europe-
an ethnicity. Participants who had not completed an OGTT
were excluded. Over 80% of the whole BiB cohort who were
eligible for an OGTT completed it and had valid data on
fasting and postload glucose levels; their characteristics were
similar to those of participants who did not complete the
OGTT [28]. Any women with pre-existing diabetes were not
invited to have an OGTT, thus by excluding women without
OGTT results we were also excluding any women with diag-
nosed existing diabetes. Following these exclusions, there
were 1,489 eligible participants for this study and, of these,
1,415 (95%) had complete data on all covariables included in
Participants with valid cord blood
samples
n=1,814  
n=1,555
Not of Pakistani or
white British ethnicity
n=259  
Eligible cohort for this study
n=1,489
No data on maternal
pregnancy glucose (excludes
those with type 1 or type 2
diabetes)
n=66    
Main analysis sample
n=1,415 (95%)
Missing  covariable
data
n=74 
Fig. 1 Flow diagram of participants
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any model; these 1415 form the main analysis sample for this
study (Fig. 1).
To be defined as Pakistani, women had to state that they
belonged to category 10 of the UK Office of National Statis-
tics criteria (Asian/British Asian subcategory and labelled
Pakistani) [29]. To be defined as white British, women had
to state that they belonged to category 1 (white subcategory
and labelled English/Welsh/Scottish/Northern Irish/British).
Full details of all of the Office of National Statistics categories
are provided in the ESM Methods. For Pakistani women,
additional information on their country of birth and that of
their partner and their parents was also collected. This con-
firmed South Asian (Indian, Pakistani or Bangladeshi) famil-
ial origin for all who had reported that they were Pakistani. In
a previous publication we have shown that differences in cord-
blood leptin levels between Pakistani and white British infants
were the same irrespective of place of birth of parents and
grandparents (i.e. generation of migration of the Pakistani
women) [10], and have not explored that further in this
paper.
Participants completed a morning OGTTafter fasting over-
night. Fasting blood samples were taken for immediate anal-
ysis. Participants then consumed a standard solution contain-
ing the equivalent of 75 g anhydrous glucose over 5 min. After
120 min a second plasma sample was taken. All glucose
assays were completed in the same laboratory in Bradford,
using a glucose oxidase method, with laboratory staff blinded
to the participants’ ethnicity or other characteristics. GDM
was defined according to modified WHO criteria operating
at the time these women were pregnant [30], as either fasting
glucose ≥6.1 mmol/l or 2 h glucose ≥7.8 mmol/l. The modi-
fication that was applied in Bradford was using a fasting
glucose threshold of ≥6.1 mmol/l. Although at the time the
threshold recommended by WHO was ≥7.0 mmol/l, GDM
was defined, including by the WHO, as any impaired glucose
tolerance diagnosed for the first time in pregnancy, hence we
used the threshold indicative of impaired fasting glucose. As a
consequence, the definition being used in these women is
similar to the recently proposed International Association of
Diabetes and Pregnancy Study Group thresholds, which are
included in the new WHO guidance [31].
Venous cord-blood samples were obtained at delivery by
the attending midwife, following research protocols. Samples
were refrigerated at 4°C in EDTA tubes until collected by
laboratory staff within 12 h. Samples were then spun, frozen
and stored at −80°C. Insulin is known to be stable in EDTA
samples at room temperature for over 24 h [32]. The samples
were transferred to Glasgow for completion of leptin and
insulin assays. Leptin was measured by a highly sensitive
in-house ELISA validated against the commercially available
Linco assay, as detailed previously [33]. Insulin was measured
by an ultrasensitive solid-phase two-site immunoassay ELISA
(Mercodia, Uppsala, Sweden) that does not cross-react with
proinsulin. Laboratory staff were blinded to the participants’
ethnicity and other characteristics.
Maternal age, education and smoking data were obtained
from the interviewer-administered questionnaire completed at
recruitment. Maternal education was equivalised to UK stan-
dard attainments and participants were included in one of five
mutually exclusive categories (full details in the ESM
Methods). Maternal smoking was categorised as never, past
(but not during this index pregnancy), current/during the index
pregnancy. Maternal BMI was calculated from height mea-
sured at the time of recruitment and from weight measured at
first antenatal clinic, which was abstracted from the antenatal
medical records; median (interquartile range) gestational age
of the mothers at this booking clinic was 12 (11–14) weeks.
Maternal parity, gestational age (to the last completed week)
and infant birthweight and sex were abstracted from the
antenatal/obstetric medical records.
Statistical analyses Maternal glucose levels and cord-blood
levels of insulin and leptin were positively skewed and were
described using medians and interquartile range. In regression
analyses that used these variables as exposures or mediators
(i.e. independent variables) they were used in their original
form (mmol/l for glucose and pmol/l for cord-blood insulin)
and in those that used them as outcomes they were natural log
transformed so that the residuals in all models were approxi-
mately normally distributed. The resultant regression coeffi-
cients were transformed so that they represent differences in
means as a percentage (%) per unit of exposure.
We tested our hypotheses in two ways. First, by a series of
separate linear regression models that examined the associa-
tions of (1) ethnicity with fasting and postload glucose levels;
(2) gestational fasting and postload glucose levels with cord-
blood levels of insulin and leptin; (3) cord-blood insulin levels
with cord-blood leptin levels; and (4) ethnicity with cord-
blood levels of insulin and leptin. In these regression models
we adjusted for maternal age, parity, smoking, education and
BMI, gestational age and offspring sex. Details of the rationale
for adjusting for these covariables are provided in the ESM
Methods. In regression analyses for the association between
ethnicity and cord-blood leptin levels, we additionally adjusted
for potential mediation by fasting/postload glucose levels and
cord-blood insulin levels.
Second, we used path analysis to simultaneously run all of
the equations from the different regression analyses and pic-
torially show the standardised regression coefficients between
exposures, potential mediators and outcomes. We included all
of the same covariables in this path analysis as in the serial
regression analysis, although on the figures we show only the
results for the main exposure, outcome and mediating path-
ways. The path analyses were done with all variables
standardised to have mean 0 and standard deviation 1 and
run using the sem command in Stata.
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We examined whether associations of glucose with cord-
blood levels of insulin and leptin were linear in each ethnic
group using fractional polynomials [34]. Differences between
white British and Pakistani participants in the associations
between gestational fasting and postload glucose levels with
outcomes were tested using an interaction (ethnicity*glucose)
test.
The main association analyses were completed in all 1,415
mother–offspring pairs and also in the 1,285 pairs after
removal of the 130 pairs in whom the mother met the criteria
for GDM.
Results
ESM Table 2 shows characteristics for all participants and
separately for Pakistani and white British women. Pakistani
women were on average older, had greater parity, were much
less likely to smoke and were more likely to be in the lowest
and highest educational attainment categories. They had
higher gestational fasting and postload glucose levels and
lower BMI. Pakistani infants had higher cord-blood levels of
insulin and leptin and lower birthweight than white British
infants. None of the associations examined in this study
differed by offspring sex (all pinteraction≥0.2) and all regression
analyses are presented with both sexes combined.
Cord-blood leptin level was positively associated with
birthweight in both ethnic groups (ESM Fig. 1). For a 1 unit
increase in logged cord-blood leptin level, birthweight in-
creased by 311 g (95% CI 267, 355) in white British women
and 263 g (95%CI 227, 302) in Pakistani women (pinteraction=
0.11). R2 values indicated that cord-blood leptin levels ex-
plained 25% and 22% of the variation in birthweight in white
British and Pakistani infants, respectively.
One hundred and thirty (9%) of the women were identified
as having GDM; it was more common in Pakistani (n=97
[12%]) than white British (n=33 [5%]) women (p<0.001).
For the vast majority of women who met the criteria, GDM
was diagnosed because of a high postload glucose level, with
77% of Pakistani and 88% of white British women with GDM
having a postload glucose level of ≥ 7.8 mmol/l but a fasting
glucose level in the normal range.
Figure 2 shows the scatter plots and unadjusted predicted
regression lines for the associations of fasting glucose with
levels of cord-blood insulin (Fig. 2a) and cord-blood leptin
(Fig. 2b) in all participants. ESM Fig. 2 shows similar results
for postload glucose and ESM Fig. 3 indicates the results
when women with GDM are removed. In both Pakistani and
white British participants, and irrespective of whether women
who met criteria for GDM were removed or not, there were
linear increases in levels of cord-blood leptin and cord-blood
insulin across the distribution of increasing maternal
gestational levels of fasting and postload glucose. The frac-
tional polynomial models supported linear associations of
both fasting and postload glucose levels with cord-blood
levels of insulin and leptin in both Pakistani and white British
women (all p values ≤0.001 for linear association and >0.2 for
any power terms).
The linear positive associations of maternal gestational
levels of fasting and postload glucose with cord-blood levels
of insulin and leptin remained with adjustment for con-
founders in both the whole cohort (ESM Table 3) and in those
who did not meet criteria for GDM (ESM Table 4). For cord-
blood levels of insulin and leptin, the magnitudes of associa-
tion were greater with fasting than with postload glucose
levels (Table 1). Associations of fasting glucose levels with
cord-blood levels of leptin and insulin were somewhat stron-
ger when women with GDMwere removed from the analyses
than when all participants were included in analyses (Table 1).
After adjustment for confounding factors, the magnitudes of
association of fasting and postload glucose levels with cord-
blood levels of insulin and leptin were similar in the two
ethnic groups. Cord-blood insulin level was positively asso-
ciated with cord-blood leptin level in both ethnic groups,
again with similar magnitudes of association between the
two ethnic groups (Table 1).
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Fig. 2 Association of maternal gestational fasting glucose levels with
infant cord-blood levels of insulin (a) and leptin (b) in white British (blue
circles; n=629) and Pakistani (red squares; n=786) mother–infant pairs
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Higher cord-blood insulin levels in Pakistani compared with
white British infants remained after adjustment for confounders
in both the whole cohort and when women with GDM were
removed (Table 2). Adjustment for potential mediation by ma-
ternal fasting glucose levels attenuated the confounder-adjusted
difference completely to the null in the whole cohort and mark-
edly when those with GDMwere excluded, whereas adjustment
for postload glucose levels reduced the difference only slightly.
Cord-blood leptin levels remained higher in Pakistani than
white British infants after adjustment for confounders, being
16% (95% CI 6, 26) and 12% (95% CI 4, 21) higher in the
whole cohort and the cohort without GDM, respectively. In
both cohorts, adjustment for potential mediation by fasting
glucose levels reduced the ethnic difference by approximately
50% and statistically the difference was consistent with the
null, whereas adjustment for postload glucose levels resulted
in very little mediation. With additional adjustment (for con-
founders and mediation by fasting glucose levels and cord-
blood insulin levels), there was a further attenuation to the null
of the ethnic difference in cord-blood leptin levels (Table 2).
Figure 3 shows the results of the path analyses for the ethnic
difference in cord-blood leptin levels in the whole cohort (with
equivalent results when thosewithGDMwere removed shown in
ESM Fig. 4). The confounder-adjusted partial correlation coeffi-
cient for the difference in cord-blood leptin levels between
Pakistani and white British women was 0.058 (p<0.001), i.e.
Pakistani infants had levels of cord-blood leptin thatwere 0.058 of
an SD higher than white British infants. This difference is calcu-
lated from the path analysis (Fig. 3) by adding together the two
paths from ethnicity to cord-blood leptin level: one that goes from
ethnicity through fasting glucose level to cord-blood leptin level
(0.18×0.26=0.047) and one that goes from ethnicity to fasting
glucose level, and from fasting glucose level to cord-blood insulin
level and from there to cord-blood leptin level (0.18×0.19×
0.31=0.011). The path analysis shows that the difference in
cord-blood leptin level between Pakistani and white British in-
fants was completely explained by higher maternal fasting glu-
cose levels amongst Pakistani women, acting both directly on
cord-blood leptin levels and explaining 0.047 SD (81%) of the
difference and also acting via cord-blood insulin levels, with that
pathway explaining 0.019 SD (19%) of the difference.
Discussion
We found positive linear associations of gestational fasting and
postload glucose levels with cord-blood levels of insulin and
leptin in both Pakistani and white British women. Pakistani
infants had higher cord-blood leptin levels, indicating greater
fat mass at birth, compared with white British infants. The
Table 1 Confounder-adjusted associations of gestational fasting and postload glucose levels with cord-blood levels of insulin and leptin in white British
and Pakistani women in all participants (n=1415) and in participants without GDM (n=1285)
Outcome Mean difference in outcome for each maternal exposure (95% CI) pinteraction
a
White British
n=629b
n=596c
Pakistani
n=786b
n=689c
Exposure=fasting glucose level (per 1 mmol/l)
Cord-blood insulin level (%) All participants 30.2 (15.6, 44.8) 24.0 (15.4, 32.5) 0.43
Participants without GDM 40.0 (21.6, 58.2) 24.7 (10.6, 38.8) 0.14
Cord-blood leptin level (%) All participants 42.2 (29.0, 55.4) 29.4 (20.7, 38.0) 0.10
Participants without GDM 48.9 (32.2, 65.6) 37.0 (22.7, 51.3) 0.24
Exposure=postload (120 min) glucose level (per 1 mmol/l)
Cord-blood insulin level (%) All participants 6.9 (1.9, 11.2) 7.5 (4.5, 10.5) 0.91
Participants without GDM 7.5 (1.3, 13.8) 5.0 (0.0, 10.5) 0.43
Cord-blood leptin level (%) All participants 8.2 (3.6, 12.8) 7.8 (4.8, 10.9) 0.79
Participants without GDM 11.1 (5.4, 16.8) 8.6 (3.1, 14.1) 0.44
Exposure=cord-blood insulin level (per pmol/l)
Cord-blood leptin level (%) All participants 0.6 (0.4, 0.7) 0.6 (0.5, 0.7) 0.55
Participants without GDM 0.7 (0.5, 0.8) 0.7 (0.5, 0.8) 0.80
All results are mean differences in the outcome expressed on a percentage scale and are adjusted for potential confounders: maternal age, BMI, parity,
smoking, education, gestational age and offspring sex. The null value is 0 for all results
a Testing the null hypothesis that associations differ between white British and Pakistani pairs
b All participants
c Participants without GDM
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magnitude of this difference was modest, with Pakistani infants
having 16% higher levels of cord-blood leptin, equating to a
0.06SD difference. Given that the birthweight of Pakistani in-
fants was >250 g lower than that of white British infants, this
difference highlights a very different body composition between
the two ethnic groups. We found that this greater birth adiposity
was largely explained by higher gestational fasting glucose
levels in women of Pakistani origin compared with white British
women, which appears to act both directly on cord-blood leptin
levels and also via increased fetal insulin secretion (as measured
here by cord-blood insulin levels).
Glucose freely crosses the placenta; therefore, the amount
delivered to the developing fetus depends upon maternal
circulating levels [15–17]. Glucose levels are higher in Paki-
stani than white British women, thus the developing fetuses of
Pakistani women will be relatively overnourished with glu-
cose, which will stimulate increased fetal pancreatic secretion
of insulin, which is a growth and fat deposition hormone. Our
regression and path analysis results support these pathways
and our original hypothesis that higher cord-blood leptin
levels (birth adiposity) in Pakistani infants is driven by higher
circulating gestational glucose levels in Pakistani women.
Table 2 Multivariable analyses of differences in cord-blood levels of leptin and insulin between Pakistani andwhite Britishmother–offspring pairs in all
participants and in participants without GDM
Outcome Modela Mean difference (%) in outcome
comparing Pakistani to white
British (95% CI)
All participants
n=1,415
Participants
without GDM
n=1,285
Cord-blood insulin level (%) Model 1: unadjusted 14 (6, 22) 10 (1, 18)
Model 2: confounder 9 (0, 19) 9 (0.4, 18)
Model 3: confounder and gestational fasting glucose level 0 (−9, 11) 5 (−4, 14)
Model 4: confounder and gestational postload glucose level 5 (−5, 15) 8 (−1, 17)
Model 5: confounder and gestational fasting and postload glucose levels 0 (−10, 10) 4 (−5, 13)
Cord-blood leptin level (%) Model 1: unadjusted 13 (4, 21) 9 (0.2, 19)
Model 2: confounder 16 (6, 26) 12 (4, 21)
Model 3: confounder and gestational fasting glucose level 7 (−3, 16) 6 (−3, 14)
Model 4: confounder and gestational postload glucose level 12 (3, 22) 10 (1, 19)
Model 5: confounder and gestational fasting and postload glucose levels 6 (−4, 16) 5 (−4, 14)
Model 6: confounder and gestational fasting glucose and cord-blood insulin levels 5 (−4, 14) 4 (−4, 12)
All results are mean differences of outcome comparing Pakistani mother–offspring pairs to White British mother–offspring pairs (reference group);
positive values indicate higher levels of outcomes in Pakistani pairs and the null value for all results is 0
aModel 1, no adjustment; model 2, adjustment for potential confounding bymaternal age, BMI, parity, smoking, education, gestational age and offspring
sex; model 3, as model 2 plus adjustment for gestational fasting glucose level; model 4, as model 2 plus adjustment for gestational postload glucose level;
model 5, as model 2 plus adjustment for gestational fasting and postload glucose levels; model 6, as model 2 plus adjustment for gestational fasting
glucose and cord-blood insulin levels
Pakistani vs white  
British
Fasting 
glucose
Cord-blood 
insulin
0.18
(0.13, 0.13)
−0.01
(−0.04, 0.03)a
Cord-blood 
leptin
0.19
(0.15, 0.22)
0.31
(0.24, 0.39)
−0.01
(−0.06, 0.04)a
0.26
(0.21, 0.31)
Fig. 3 Path analysis for differences in cord-blood leptin levels between
Pakistani and white British individuals (n=1415). The results are
standardised regression coefficients, with their 95% CIs, and are adjusted
for maternal age, parity and education, infant sex and gestational age.
They are interpreted as the adjusted change in outcome (box at the end of
the arrow head) in SD units per category (ethnicity) or per SD of the
exposure (arrow start). p<0.001 for all results except those indicated
ap≥0.50
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We undertook analyses both including and excludingwomen
who met clinical criteria for GDM. In the Bradford Royal
Infirmary, once identified, women with GDM will have been
treated as clinically indicated with diet and exercise, metformin,
or insulin to achieve and maintain euglycaemia. Treatment
protocols are applied identically to women of all ethnicities.
Women identified as having GDM are likely to have had lower
glucose levels on average during the last trimester than if they
had not been identified and treated; however, these women
represent the upper end of the risk distribution and will have
had higher glucose levels in earlier pregnancy and we felt it was
important to examine relationships in the cohort with these
women included as well as with them excluded. Overall, the
mediation analyses were similar in cohorts that included or
excluded women with GDM, with some minor differences
between each stage of the regression and path analyses. GDM
was more common in Pakistani than white British women,
consistent with their higher levels of fasting and postload glu-
cose, but in both ethnic groups most women were diagnosed
with GDM on the basis of having elevated postload glucose
levels. However, fasting glucose level was more strongly related
to cord-blood levels of insulin and leptin than was postload
glucose level, thus irrespective of inclusion or exclusion of those
with GDM, the mediation by fasting glucose levels was similar.
To the best of our knowledge, this study is the first to
examine the possibility that birth differences in cord-blood
leptin levels between South Asian and white European popu-
lations is mediated by differences in gestational glycaemia. We
used cord-blood insulin levels as a proxy for fetal insulin
secretion and cord-blood leptin levels as a proxy for birth
fatness. Maternal insulin does not cross the placenta and the
fetus secrets insulin in relation to maternal levels of circulating
glucose; the anabolic effects of insulin are then key for fetal fat
deposition [15–17]. However, cord-blood insulin levels may
also reflect insulin sensitivity at birth. Whilst it is difficult to
determine how much of the variation in cord-blood insulin
levels was due to offspring insulin sensitivity at birth, this
sensitivity is likely to reflect only a small proportion of the
variation, with variation largely reflecting fetal secretion [35,
36]. Leptin is found in fetal adipose tissue, and cord-blood
leptin level is strongly positively related to fetal fat mass,
explaining approximately 20–25% of variation in fat mass
[26, 27], similar to the variation of birthweight that we found
here. Whilst it is known that the placenta secretes leptin, the
vast majority of this leptin is secreted into the maternal circu-
lation, with less than 1% of cord-blood leptin estimated to be
from the placenta/maternal circulation [37, 38]. Recent findings
show that maternal gestational serum leptin level is not associ-
ated with cord-blood leptin level and is higher in women with a
fetus with intrauterine growth restriction, whereas cord-blood
leptin level is positively associated with birthweight [38]. These
findings support cord-blood leptin level as reflecting fat mass at
birth. Whilst we are unaware of any study examining whether
cord-blood leptin level relates to fat mass with the same mag-
nitude in European and South Asian infants, we found that the
association of cord-blood leptin level with birthweight was the
same in both groups, which is consistent with our previous
more detailed study of these relationships [39].
Our study is observational and cannot prove causality. To
assume the observed associations represent causal paths
means assuming that measurement error between ethnicity
and the mediators, and the mediators and cord-blood leptin,
are minimal and/or are not correlated with each other [40].
Ethnicity was self-reported but verified by family tree infor-
mation and country of birth of family members. Gestational
glucose and cord-blood measurements were completed using
valid procedures and with the laboratory staff unaware of
participant characteristics. Claiming causal mediation would
also assume that there is no residual confounding. Mendelian
randomisation (using genetic variants that are known to be
robustly associated with fasting glucose levels as proxies for
its causal effect) has shown a causal effect of fasting glucose
levels on birthweight, which together with the known physi-
ology of pregnancy in relation to maternal glucose and fetal
insulin, supports a causal effect of fasting glucose levels on
fetal fatness. However, further replication of these findings
and testing causal pathways through randomised controlled
trials and/or Mendelian randomisation is warranted.
The South Asian participants in our study are all of
Pakistani origin and we cannot assume that our results neces-
sarily generalise to other South Asian populations. Likewise,
the white British population may not be representative of all
white European populations. However, other studies suggest
similar differences in infant fat mass between Indian and white
European infants [7–9].
Leptin regulates energy homeostasis by relaying informa-
tion about the body’s energy and nutrient stores from the
periphery to the brain [41]. However, adult humans inWestern
populations are largely resistant to this regulatory mechanism,
with recent evidence suggesting that leptin resistance is pres-
ent in children as young as 7 and 12 years of age [42, 43]. By
contrast, two studies of 200 and 600 participants have shown
that cord-blood leptin levels are inversely related to BMI at
age 2–3 years [44, 45], with these findings interpreted as
showing that there might be a period of leptin sensitivity in
early human life. Both of these studies were conducted in
European origin children and whether similar results would
be seen in South Asian infants is yet to be determined. Fur-
thermore, the substantial evidence of greater fatness, insulin
resistance, type 2 diabetes and markedly higher leptin levels in
South Asian children and adults compared with Europeans [1,
11–14, 20–25] argues against any leptin sensitivity in infancy
having a lasting beneficial impact, but rather that higher leptin
and fat mass levels are maintained in South Asians.
Our results provide further evidence of the higher preva-
lence of hyperglycaemia in South Asian than white British
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women and the potential adverse effects in terms of greater
adiposity in the offspring of South Asian women. These
findings suggest that current guidelines for the detection and
control of hyperglycaemia and GDM in South Asian women
should be rigorously applied. Selecting women for GDM
testing on the basis of risk factors, as currently practised in
most of the UK and many other countries, could miss nearly
half of all cases of GDM in South Asian women because of
failure to rigorously apply risk factor screening [46, 47].
Furthermore, to our knowledge, there is no randomised con-
trolled trial evidence of the effect of treating GDM (or those at
risk of GDM) specifically in South Asian women, despite
their greater risk and differing lifestyles compared with white
European women. In the most recent Cochrane systematic
review, which included eight trials, none seem to have includ-
ed any or sufficient South Asian women to determine effects
in that population [48]. We were able to identify just one trial
in South Asian women, which was a pilot randomised trial in
India that aimed to compare the relative effects on GDM of
two different types of insulin therapy [49].
In conclusion, we have shown that compared with white
British infants, Pakistani infants have higher absolute cord-
blood leptin levels, reflecting greater birth fat mass despite
their lower birthweight. Importantly, we found that higher
maternal gestational glucose levels explain this greater birth
fat mass. Given the rapidly rising levels of diabetes in South
Asian populations, these results warrant further exploration
and, if replicated, the possibility of more aggressive identifi-
cation and treatment of hyperglycaemia in pregnancy in South
Asian women should be explored.
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